Mostrar el registro sencillo del ítem

dc.contributor.authorCastro Portillo, Enrique
dc.contributor.authorLópez Izquierdo, Raúl 
dc.contributor.authorCastro Villamor, Miguel Ángel 
dc.contributor.authorSanz García, Ancor
dc.contributor.authorMartín Conty, José Luis
dc.contributor.authorPolonio López, Begoña
dc.contributor.authorSánchez Soberón, Irene
dc.contributor.authorPozo Vegas, Carlos del 
dc.contributor.authorDurántez Fernández, Carlos 
dc.contributor.authorConty Serrano, Rosa
dc.contributor.authorMartín Rodríguez, Francisco 
dc.date.accessioned2024-08-20T11:54:44Z
dc.date.available2024-08-20T11:54:44Z
dc.date.issued2023
dc.identifier.citationJournal of Cardiovascular Development and Disease, 2023, Vol. 10, Nº. 2, 88es
dc.identifier.issn2308-3425es
dc.identifier.urihttps://uvadoc.uva.es/handle/10324/69385
dc.descriptionProducción Científicaes
dc.description.abstract(1) Background: The Modified Sequential Organ Failure Assessment (mSOFA) is an Early Warning Score (EWS) that has proven to be useful in identifying patients at high risk of mortality in prehospital care. The main objective of this study was to evaluate the predictive validity of prehospital mSOFA in estimating 2- and 90-day mortality (all-cause) in patients with acute cardiovascular diseases (ACVD), and to compare this validity to that of four other widely-used EWS. (2) Methods: We conducted a prospective, observational, multicentric, ambulance-based study in adults with suspected ACVD who were transferred by ambulance to Emergency Departments (ED). The primary outcome was 2- and 90-day mortality (all-cause in- and out-hospital). The discriminative power of the predictive variable was assessed and evaluated by the area under the curve (AUC) of the receiver operating characteristic (ROC). (3) Results: A total of 1540 patients met the inclusion criteria. The 2- and 90-day mortality rates were 5.3% and 12.7%, respectively. The mSOFA showed the highest AUC of all the evaluated scores for both 2- and 90-day mortality, AUC = 0.943 (0.917–0.968) and AUC = 0.874 (0.847–0.902), respectively. (4) Conclusions: The mSOFA is a quick and easy-to-use EWS with an excellent ability to predict mortality at both 2 and 90 days in patients treated for ACVD, and has proved to be superior to the other EWS evaluated in this study.es
dc.format.mimetypeapplication/pdfes
dc.language.isoenges
dc.publisherMDPIes
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectCardiovascular system - Diseaseses
dc.subjectCardiovascular, Aparato - Enfermedadeses
dc.subjectCardiovascular Diseaseses
dc.subjectEnfermedad cardiovasculares
dc.subjectBiomarkerses
dc.subjectEarly warning systemes
dc.subjectEmergency medical serviceses
dc.subjectMedicina de urgenciases
dc.subjectAtención prehospitalariaes
dc.subjectMortalityes
dc.subjectMortalidades
dc.subjectMedicinees
dc.subjectCardiologyes
dc.subjectPublic healthes
dc.titleModified sequential organ failure assessment score vs. early warning scores in prehospital care to predict major adverse cardiac events in acute cardiovascular diseasees
dc.typeinfo:eu-repo/semantics/articlees
dc.rights.holder© 2023 The authorses
dc.identifier.doi10.3390/jcdd10020088es
dc.relation.publisherversionhttps://www.mdpi.com/2308-3425/10/2/88es
dc.identifier.publicationfirstpage88es
dc.identifier.publicationissue2es
dc.identifier.publicationtitleJournal of Cardiovascular Development and Diseasees
dc.identifier.publicationvolume10es
dc.peerreviewedSIes
dc.description.projectJunta de Castilla y León, Gerencia Regional de Salud - (grant GRS 1903/A/19 and GRS 2131/A/20)es
dc.identifier.essn2308-3425es
dc.rightsAtribución 4.0 Internacional*
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones
dc.subject.unesco32 Ciencias Médicases
dc.subject.unesco3205.01 Cardiologíaes
dc.subject.unesco3207.04 Patología Cardiovasculares
dc.subject.unesco3212 Salud Publicaes


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem